|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 577 active entries
P.O. Box 722
Leiden, 2300 AS, The Netherlands
Phone: +31 (71) 5244044
Fax: +31 (71) 5244043
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
OctoPlus is a Dutch company active in the field of biotechnological and pharmaceutical development with a special expertise in product formulation.
OctoPlus supplies formulation development capacity and drug delivery technology to its clients.
OctoPlus' specialised and proprietary technologies include liposomes, microspheres, protein formulations and non-viral systems for gene delivery.
Services include analytical development and validation, process development, upscaling and optimisation and troubleshooting.
Proprietary technologies are non-viral vectors for gene therapy, biodegradable hydrogels and biodegradable microspheres.
OctoPlus' staff has brought several products to the market/clinic:
- Injectable (recombinant) proteins
- Liposomal formulations
- Solid dosage forms
- Semi-solid dosage forms
For more information, please contact Dr. J.J.M. Holthuis or Prof. Dr. D.J.A. Crommelin.
Last update of this entry: June 28, 2004